Favipiravir ribofuranose metabolite

SL-10598

Favipiravir ribofuranose metabolite, >98%

IUPAC Name : 4-((2S,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an analog of Favipiravir, which is a potent and selective RNA-dependent RNA polymerase inhibitor, used to treat influenza virus infections. Also, this is a COVID-19 related research chemical.

References : Furuta Y. et al.: Antimicrob Agents Chemother., 46(4), 977-981, 2002; Baranovich T. et al.: J. Virol., 87(7), 3741-3751, 2013; Madelain V. et al.: Antiviral Res., 123, 70-77, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.